SNT CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 264 JPY | -1.12% |
|
+0.76% | +0.38% |
| Apr. 19 | Earnings Flash (SNT) SENSTAR TECHNOLOGIES CORPORATION Posts Q4 Revenue $8.9M | MT |
| Apr. 10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 22,010 | 17,693 | 8,210 | 10,629 | 8,211 | 8,945 |
| Enterprise Value (EV) 1 | 12,119 | 7,403 | 3,831 | 5,853 | 2,324 | 3,343 |
| P/E ratio | 14.6 x | 13.4 x | -38.1 x | -19.4 x | 19.1 x | 15.1 x |
| Yield | 1.9% | 2.36% | 4.46% | 3.45% | 4.46% | 4.1% |
| Capitalization / Revenue | 1.01 x | 0.78 x | 0.42 x | 0.7 x | 0.48 x | 0.41 x |
| EV / Revenue | 0.56 x | 0.33 x | 0.2 x | 0.38 x | 0.13 x | 0.15 x |
| EV / EBITDA | 4.46 x | 2.65 x | 2.03 x | 8.26 x | 1.27 x | 1.49 x |
| EV / FCF | 17.3 x | 5.22 x | -20.1 x | 10.3 x | 3.45 x | -3.01 x |
| FCF Yield | 5.79% | 19.1% | -4.98% | 9.68% | 29% | -33.2% |
| Price to Book | 0.71 x | 0.58 x | 0.34 x | 0.46 x | 0.36 x | 0.36 x |
| Nbr of stocks (in thousands) | 49,129 | 49,148 | 36,650 | 36,653 | 36,654 | 36,658 |
| Reference price 2 | 448.0 | 360.0 | 224.0 | 290.0 | 224.0 | 244.0 |
| Announcement Date | 6/28/18 | 6/27/19 | 6/26/20 | 6/28/21 | 6/29/22 | 6/28/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 21,752 | 22,769 | 19,337 | 15,214 | 17,248 | 21,738 |
| EBITDA 1 | 2,716 | 2,795 | 1,890 | 709 | 1,827 | 2,239 |
| EBIT 1 | 1,560 | 1,722 | 768 | -607 | 523 | 814 |
| Operating Margin | 7.17% | 7.56% | 3.97% | -3.99% | 3.03% | 3.74% |
| Earnings before Tax (EBT) 1 | 2,057 | 1,828 | 305 | -470 | 722 | 966 |
| Net income 1 | 1,508 | 1,317 | -278 | -547 | 429 | 594 |
| Net margin | 6.93% | 5.78% | -1.44% | -3.6% | 2.49% | 2.73% |
| EPS 2 | 30.69 | 26.80 | -5.886 | -14.92 | 11.70 | 16.20 |
| Free Cash Flow 1 | 701.4 | 1,417 | -190.9 | 566.9 | 674 | -1,110 |
| FCF margin | 3.22% | 6.22% | -0.99% | 3.73% | 3.91% | -5.11% |
| FCF Conversion (EBITDA) | 25.82% | 50.71% | - | 79.95% | 36.89% | - |
| FCF Conversion (Net income) | 46.51% | 107.61% | - | - | 157.11% | - |
| Dividend per Share 2 | 8.500 | 8.500 | 10.00 | 10.00 | 10.00 | 10.00 |
| Announcement Date | 6/28/18 | 6/27/19 | 6/26/20 | 6/28/21 | 6/29/22 | 6/28/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 10,205 | 6,538 | 8,100 | 4,115 | 5,181 | 10,558 | 5,678 | 5,604 | 11,142 | 5,604 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 480 | -839 | 223 | 105 | 199 | 389 | 233 | 71 | 295 | 359 |
| Operating Margin | 4.7% | -12.83% | 2.75% | 2.55% | 3.84% | 3.68% | 4.1% | 1.27% | 2.65% | 6.41% |
| Earnings before Tax (EBT) 1 | 518 | -622 | 309 | 202 | 292 | 515 | 270 | 686 | 979 | 420 |
| Net income 1 | 727 | -613 | 155 | 178 | 167 | 265 | 190 | 522 | 709 | 323 |
| Net margin | 7.12% | -9.38% | 1.91% | 4.33% | 3.22% | 2.51% | 3.35% | 9.31% | 6.36% | 5.76% |
| EPS 2 | 14.80 | -16.73 | 4.230 | 4.880 | 4.560 | 7.230 | 5.190 | 14.25 | 19.34 | 8.810 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/14/19 | 11/13/20 | 11/12/21 | 2/14/22 | 8/10/22 | 11/11/22 | 2/13/23 | 8/10/23 | 11/13/23 | 2/13/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 9,891 | 10,290 | 4,379 | 4,776 | 5,887 | 5,602 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 701 | 1,417 | -191 | 567 | 674 | -1,110 |
| ROE (net income / shareholders' equity) | 5.04% | 4.3% | -0.97% | -2.32% | 1.87% | 2.51% |
| ROA (Net income/ Total Assets) | 2.5% | 2.72% | 1.27% | -1.06% | 0.93% | 1.37% |
| Assets 1 | 60,325 | 48,449 | -21,885 | 51,594 | 46,368 | 43,345 |
| Book Value Per Share 2 | 629.0 | 625.0 | 658.0 | 631.0 | 625.0 | 670.0 |
| Cash Flow per Share 2 | 226.0 | 231.0 | 288.0 | 270.0 | 299.0 | 322.0 |
| Capex 1 | 1,289 | 918 | 1,637 | 834 | 1,116 | 1,169 |
| Capex / Sales | 5.93% | 4.03% | 8.47% | 5.48% | 6.47% | 5.38% |
| Announcement Date | 6/28/18 | 6/27/19 | 6/26/20 | 6/28/21 | 6/29/22 | 6/28/23 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +0.38% | 62.95M | |
| -0.81% | 25.96B | |
| +17.20% | 20.84B | |
| -7.59% | 11.99B | |
| +24.52% | 11.31B | |
| +10.90% | 10.86B | |
| +9.59% | 10.04B | |
| -5.13% | 7.95B | |
| +28.10% | 7.24B | |
| +1.09% | 7.11B |
- Stock Market
- Equities
- 6319 Stock
- Financials SNT Corporation
